PE and VC’s fortunes are starting to diverge materially. PE healthcare specialists are outraising the broader asset class, with bigger fundraises and more frequent above target closes. Meanwhile, VC healthcare and life sciences fundraising declined as a proportion of overall VC fundraising. Moreover, as PE healthcare investing has become more competitive and complex in recent years, firms are becoming more operationally and thematically sophisticated. As allocators continue to re-evaluate their alternatives allocations, PitchBook’s lead healthcare analyst Rebecca Springer breaks down capital formation within the sector.
Read the full article: PitchBook’s H1 2024 Healthcare Funds Report //
Source: https://pitchbook.com/news/reports/h1-2024-healthcare-funds-report